Invention Grant
US07718767B2 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection 有权
3-醚和3-硫醚取代的环孢菌素衍生物用于治疗和预防丙型肝炎感染

  • Patent Title: 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
  • Patent Title (中): 3-醚和3-硫醚取代的环孢菌素衍生物用于治疗和预防丙型肝炎感染
  • Application No.: US11386291
    Application Date: 2006-03-21
  • Publication No.: US07718767B2
    Publication Date: 2010-05-18
  • Inventor: Hans Georg FliriDavid Renwick Houck
  • Applicant: Hans Georg FliriDavid Renwick Houck
  • Applicant Address: US NC Research Triangle Park
  • Assignee: Scynexis, Inc.
  • Current Assignee: Scynexis, Inc.
  • Current Assignee Address: US NC Research Triangle Park
  • Agency: Jones Day
  • Main IPC: C07K7/64
  • IPC: C07K7/64
3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
Abstract:
This invention relates to cyclosporin derivatives of general formula (I): wherein A, B, R1, R2 and X are as defined in the specification, and pharmaceutical compositions prepared from the same, for use in treatment of hepatitis C virus.
Information query
Patent Agency Ranking
0/0